Filing Details
- Accession Number:
- 0001012975-17-000474
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-06-06 16:49:26
- Reporting Period:
- 2017-06-02
- Filing Date:
- 2017-06-06
- Accepted Time:
- 2017-06-06 16:49:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1326190 | Altimmune Inc. | ALT | Pharmaceutical Preparations (2834) | 202726770 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1409939 | John Gill | C/O Altimmune, Inc. 19 Firstfield Road, Suite 200 Gaithersburg MD 20878 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.0001 | Acquisiton | 2017-06-02 | 1,000 | $4.34 | 83,224 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
